ArticleBiomedicines2022

Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway.

Yu-Jung Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.